These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 19667141)
1. The impact of 1,25(OH)2D3 and its structural analogs on gene expression in cancer cells--a microarray approach. Kriebitzsch C; Verlinden L; Eelen G; Tan BK; Van Camp M; Bouillon R; Verstuyf A Anticancer Res; 2009 Sep; 29(9):3471-83. PubMed ID: 19667141 [TBL] [Abstract][Full Text] [Related]
2. Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays. Krishnan AV; Shinghal R; Raghavachari N; Brooks JD; Peehl DM; Feldman D Prostate; 2004 May; 59(3):243-51. PubMed ID: 15042599 [TBL] [Abstract][Full Text] [Related]
3. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells. Khanim FL; Gommersall LM; Wood VH; Smith KL; Montalvo L; O'Neill LP; Xu Y; Peehl DM; Stewart PM; Turner BM; Campbell MJ Oncogene; 2004 Sep; 23(40):6712-25. PubMed ID: 15300237 [TBL] [Abstract][Full Text] [Related]
4. Microarray analysis of MCF-7 breast cancer cells treated with 1,25-dihydroxyvitamin D3 or a 17-methyl-D-ring analog. Vanoirbeek E; Eelen G; Verlinden L; Marchal K; Engelen K; De Moor B; Beullens I; Marcelis S; De Clercq P; Bouillon R; Verstuyf A Anticancer Res; 2009 Sep; 29(9):3585-90. PubMed ID: 19667152 [TBL] [Abstract][Full Text] [Related]
5. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells. Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613 [TBL] [Abstract][Full Text] [Related]
6. Identification of VDR-responsive gene signatures in breast cancer cells. Towsend K; Trevino V; Falciani F; Stewart PM; Hewison M; Campbell MJ Oncology; 2006; 71(1-2):111-23. PubMed ID: 17377416 [TBL] [Abstract][Full Text] [Related]
7. Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Lin R; Nagai Y; Sladek R; Bastien Y; Ho J; Petrecca K; Sotiropoulou G; Diamandis EP; Hudson TJ; White JH Mol Endocrinol; 2002 Jun; 16(6):1243-56. PubMed ID: 12040012 [TBL] [Abstract][Full Text] [Related]
8. The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells. Myrthue A; Rademacher BL; Pittsenbarger J; Kutyba-Brooks B; Gantner M; Qian DZ; Beer TM Clin Cancer Res; 2008 Jun; 14(11):3562-70. PubMed ID: 18519790 [TBL] [Abstract][Full Text] [Related]
9. Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Swami S; Raghavachari N; Muller UR; Bao YP; Feldman D Breast Cancer Res Treat; 2003 Jul; 80(1):49-62. PubMed ID: 12889598 [TBL] [Abstract][Full Text] [Related]
10. Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Pálmer HG; Sánchez-Carbayo M; Ordóñez-Morán P; Larriba MJ; Cordón-Cardó C; Muñoz A Cancer Res; 2003 Nov; 63(22):7799-806. PubMed ID: 14633706 [TBL] [Abstract][Full Text] [Related]
11. 1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells. Fernandez-Garcia NI; Palmer HG; Garcia M; Gonzalez-Martin A; del Rio M; Barettino D; Volpert O; Muñoz A; Jimenez B Oncogene; 2005 Sep; 24(43):6533-44. PubMed ID: 16007183 [TBL] [Abstract][Full Text] [Related]
12. Amphiregulin is a vitamin D3 target gene in squamous cell and breast carcinoma. Akutsu N; Bastien Y; Lin R; Mader S; White JH Biochem Biophys Res Commun; 2001 Mar; 281(4):1051-6. PubMed ID: 11237771 [TBL] [Abstract][Full Text] [Related]
13. Effects of 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. González-Sancho JM; Larriba MJ; Ordóñez-Morán P; Pálmer HG; Muñoz A Anticancer Res; 2006; 26(4A):2669-81. PubMed ID: 16886677 [TBL] [Abstract][Full Text] [Related]
14. Vitamin D compounds: activity against microbes and cancer. Gombart AF; Luong QT; Koeffler HP Anticancer Res; 2006; 26(4A):2531-42. PubMed ID: 16886661 [TBL] [Abstract][Full Text] [Related]
15. Microarray analysis of 1alpha,25-dihydroxyvitamin D3-treated MC3T3-E1 cells. Eelen G; Verlinden L; Van Camp M; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):405-7. PubMed ID: 15225810 [TBL] [Abstract][Full Text] [Related]
16. The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. Aguilera O; Peña C; García JM; Larriba MJ; Ordóñez-Morán P; Navarro D; Barbáchano A; López de Silanes I; Ballestar E; Fraga MF; Esteller M; Gamallo C; Bonilla F; González-Sancho JM; Muñoz A Carcinogenesis; 2007 Sep; 28(9):1877-84. PubMed ID: 17449905 [TBL] [Abstract][Full Text] [Related]
17. Molecular activity of 1,25-dihydroxyvitamin D3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis. Peehl DM; Shinghal R; Nonn L; Seto E; Krishnan AV; Brooks JD; Feldman D J Steroid Biochem Mol Biol; 2004 Oct; 92(3):131-41. PubMed ID: 15555907 [TBL] [Abstract][Full Text] [Related]
18. Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly. Reddy GS; Robinson M; Wang G; Palmore GT; Gennaro L; Vouros P; De Clercq P; Vandewalle M; Young W; Ling S; Verstuyf A; Bouillon R Arch Biochem Biophys; 2007 Apr; 460(2):254-61. PubMed ID: 17196157 [TBL] [Abstract][Full Text] [Related]
19. Modulation of 1alpha,25-dihydroxyvitamin D3-membrane associated, rapid response steroid binding protein expression in mouse odontoblasts by 1alpha,25-(OH)2D3. Teillaud C; Nemere I; Boukhobza F; Mathiot C; Conan N; Oboeuf M; Hotton D; Macdougall M; Berdal A J Cell Biochem; 2005 Jan; 94(1):139-52. PubMed ID: 15523675 [TBL] [Abstract][Full Text] [Related]
20. Vitamin D analogs and coactivators. Eelen G; Verlinden L; De Clercq P; Vandewalle M; Bouillon R; Verstuyf A Anticancer Res; 2006; 26(4A):2717-21. PubMed ID: 16886682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]